Barclays Maintains an 'Equalweight' on Global Partners (GLP); 3Q Beat but Margin Pressure Persists
Get Alerts GLP Hot Sheet
Price: $50.88 +0.10%
Rating Summary:
2 Buy, 2 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
2 Buy, 2 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Barclays maintains an 'Equalweight' on Global Partners, L.P. (NYSE: GLP) price target of $22.00.
Barclays analyst says, "Strong contribution from retail gas station acquisition drives better-than-expected results but 2011 distribution coverage remains tight. Unfavorable distillate and gasoline forward curve drives tight coverage in 2011. However, solid cash flow generation from the New England gas station acquisition is a bright spot and will help GLP post 1.0x distribution coverage. Combining positive 3Q results, management reaffirmation of 2011 EBITDA guidance, cost cutting initiatives and new organic projects, we expect cash flow and distribution coverage to improve in 2012."
For more ratings news on Global Partners, L.P. click here and for the rating history of Global Partners, L.P. click here.
Shares of Global Partners, L.P. closed at $20.70 yesterday.
Barclays analyst says, "Strong contribution from retail gas station acquisition drives better-than-expected results but 2011 distribution coverage remains tight. Unfavorable distillate and gasoline forward curve drives tight coverage in 2011. However, solid cash flow generation from the New England gas station acquisition is a bright spot and will help GLP post 1.0x distribution coverage. Combining positive 3Q results, management reaffirmation of 2011 EBITDA guidance, cost cutting initiatives and new organic projects, we expect cash flow and distribution coverage to improve in 2012."
For more ratings news on Global Partners, L.P. click here and for the rating history of Global Partners, L.P. click here.
Shares of Global Partners, L.P. closed at $20.70 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Canaccord Downgrades York Space Systems (YSS) to Hold, 'Supply chain and contract timing uncertainty'
- Stifel on EyePoint Inc. (EYPT): 'we think these data bode well for LUCIA (expected October) barring another unusual asymmetry'
- BofA Securities Starts Definium Therapeutics Inc (DFTX) at Buy
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
BarclaysSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share